We extended these studies to human non-small cell lung carcinoma cells, H1299, and two independent stable transfectants expressing shRNA against RAD9 (H1299shRAD9), wherein the corresponding protein levels were reduced 70-80% relative to the untransfected control (Figure 2A). Here, RAD9A is linked to non-small cell lung carcinoma.